María Esperanza
Rodríguez Ruiz
Consultora Médica
Publicaciones en las que colabora con María Esperanza Rodríguez Ruiz (11)
2021
-
Paradigms on immunotherapy combinations with chemotherapy
Cancer Discovery, Vol. 11, Núm. 6, pp. 1353-1367
2020
-
Endoscopical and pathological dissociation in severe colitis induced by immune-checkpoint inhibitors
OncoImmunology, Vol. 9, Núm. 1
-
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Science Translational Medicine, Vol. 12, Núm. 565
2019
-
Cytokines in clinical cancer immunotherapy
British Journal of Cancer, Vol. 120, Núm. 1, pp. 6-15
-
Immune mechanisms mediating abscopal effects in radioimmunotherapy
Pharmacology and Therapeutics, Vol. 196, pp. 195-203
-
TGFb blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies
Molecular Cancer Therapeutics, Vol. 18, Núm. 3, pp. 621-631
2018
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain
Cancer Immunology, Immunotherapy
2014
-
A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: The University of Navarre predictive model
Brachytherapy, Vol. 13, Núm. 4, pp. 400-404
-
Phase II trial of image-based high-dose-rate interstitial brachytherapy for previously irradiated gynecologic cancer
Brachytherapy, Vol. 13, Núm. 3, pp. 219-224
-
Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed
Journal of Translational Medicine, Vol. 12, Núm. 1